Genetic predisposition to neuroblastoma mediated by a LMO1 super-enhancer polymorphism

Nature. Volume 528: p.418-421, 11 November 2015 10.1038/nature15540

Neuroblastoma is a paediatric malignancy that typically arises in early childhood, and is derived from the developing sympathetic nervous system. Clinical phenotypes range from localized tumours with excellent outcomes to widely metastatic disease in which long-term survival is approximately 40% despite intensive therapy. A previous genome-wide association study identified common polymorphisms at the LMO1 gene locus that are highly associated with neuroblastoma susceptibility and oncogenic addiction to LMO1 in the tumour cells. Here we investigate the causal DNA variant at this locus and the mechanism by which it leads to neuroblastoma tumorigenesis. We first imputed all possible genotypes across the LMO1 locus and then mapped highly associated single nucleotide polymorphism (SNPs) to areas of chromatin accessibility, evolutionary conservation and transcription factor binding sites. We show that SNP rs2168101 G>T is the most highly associated variant (combined P = 7.47 × 10(-29), odds ratio 0.65, 95% confidence interval 0.60-0.70), and resides in a super-enhancer defined by extensive acetylation of histone H3 lysine 27 within the first intron of LMO1. The ancestral G allele that is associated with tumour formation resides in a conserved GATA transcription factor binding motif. We show that the newly evolved protective TATA allele is associated with decreased total LMO1 expression (P = 0.028) in neuroblastoma primary tumours, and ablates GATA3 binding (P < 0.0001). We demonstrate allelic imbalance favouring the G-containing strand in tumours heterozygous for this SNP, as demonstrated both by RNA sequencing (P < 0.0001) and reporter assays (P = 0.002). These findings indicate that a recently evolved polymorphism within a super-enhancer element in the first intron of LMO1 influences neuroblastoma susceptibility through differential GATA transcription factor binding and direct modulation of LMO1 expression in cis, and this leads to an oncogenic dependency in tumour cells.

In order to access Controlled TARGET NBL data using the links below, users must submit an application for Authorized Access via dbGaP as described on dbGaP’s TARGET Study Page. To begin the application process, please view the information and instructions provided on the dbGaP Authorized Access Login Page under “dbGaP Data Download”.

Supplemental Data

• GDC Manifests
  • Controlled-Access Data Download Manifest (11 Files)
  • Open-Access Data Download Manifest (23 Files)
  • WGS CGI Files Download Manifest (137 Files)

• Copy Number Array
  • TARGET NBL Copy number array Level 1 Data (Controlled)
  • TARGET NBL Copy number array Level 2 Data (Controlled)
  • TARGET NBL Copy number array Level 3 Data
  • TARGET NBL Copy number array Design Information
  • TARGET NBL Copy number array Metadata
• Gene Expression Array
  • TARGET NBL Gene expression array Level 1 Data (Controlled)
  • TARGET NBL Gene expression array Level 2 Data (Controlled)
  • TARGET NBL Gene expression array Level 3 Data
  • TARGET NBL Gene expression array Metadata
• mRNA-Seq
  • TARGET NBL RNA-seq Level 3 data
  • TARGET NBL RNA-seq Level 3 data (Controlled)
  • TARGET NBL RNA-seq Metadata
• miRNA-Seq
  • TARGET NBL miRNA-seq Level 3 Data
  • TARGET NBL miRNA-seq Metadata
• Whole Exome Sequencing
  • TARGET NBL WXS Level 3 Data
  • TARGET NBL WXS Level 3 Data (Controlled)
  • TARGET NBL WXS Metadata
• Methylation Array
  • TARGET NBL Methylation array Level 1 Data (Controlled)
  • TARGET NBL Methylation array Level 2 Data
  • TARGET NBL Methylation array Level 3 Data
  • TARGET NBL Methylation array Metadata
• Whole Genome Sequencing
  • TARGET NBL WGS Level 3 Data
  • TARGET NBL WGS Level 3 Data (Controlled)
  • TARGET NBL WGS Level 4 Data
  • TARGET NBL WGS Metadata
• Targeted Capture Sequencing
  • TARGET NBL Targeted Capture Sequencing Level 3 Data
  • TARGET NBL Targeted Capture Sequencing Level 3 Data (Controlled)
  • TARGET NBL Targeted Capture Sequencing Design
  • TARGET NBL Targeted Capture Sequencing Metadata
• GWAS
  • TARGET NBL GWAS Level 2 Data (Controlled)
• Miscellaneous Files
  • TARGET NBL Sample Matrices
  • TARGET NBL ID Mapping Information
  • TARGET NBL CGI Requested Reports (Controlled)

Additional Resources

• OCG TARGET Data Matrix (link is external) Office of Cancer Genomics
• TARGET-NBL at SRA (link is external) NCBI

Instructions for Data Download

Open Access Data

1. Download the appropriate manifest file from the publication page
2. Use the manifest file to download data using the GDC Data Transfer Tool (DTT) or the GDC API
   • GDC DTT ( Download, User's Guide)
   • GDC API ( User’s Guide)

Controlled Access Data

1. Download the appropriate manifest file from the publication page
2. Download a token from the GDC Data Portal
   • GDC Data Portal ( Launch, User’s Guide)
3. Use the manifest file and token to download data using the GDC DTT or the GDC API
   • GDC DTT ( Download, User’s Guide)
   • GDC API ( User’s Guide)

For assistance, please contact the GDC Help Desk: support@nci-gdc.datacommons.io.